New Long-Acting shot may ease Post-Surgery pain for days

NCT ID NCT04578483

Completed Symptom relief Sponsor: China Medical University Hospital Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study looked at how well a long-acting painkiller called ERDS works for pain after surgery. Researchers followed 634 adults who received an ERDS injection after anesthesia. They measured pain levels and how much extra pain medicine was needed over five days. The goal was to see if this approach could improve recovery and reduce complications.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: extended-release dinalbuphine sebacate (ERDS)
What this could lead to: If it works, this could provide a longer-lasting option for managing pain after surgery, potentially reducing complications and the need for other painkillers.
What could go wrong: This is an observational study, not a randomized trial, so results may be less reliable. The drug's effectiveness and safety need further testing in larger, controlled studies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POSTOPERATIVE PAIN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

agnosia Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

POSTOPERATIVE PAIN

Contacts and locations

Locations

China Medical University Hsinchu Hospital

Hsinchu, 302, Taiwan

More trials for these conditions

Other studies related to the condition(s) this trial covers.